Can a probiotic improve memory in adults with mild cognitive decline?
Part of Mental health clinical trials.
This trial tests whether a daily probiotic called Lacticaseibacillus paracasei PS23 can help improve thinking and memory in adults aged 50 to 85 who feel their memory is slipping but do not have dementia or Alzheimer's disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 50 and 85 years old.
- You should feel your memory or thinking is not as sharp as it used to be.
- You must not have been diagnosed with dementia or Alzheimer's disease.
- You cannot have taken antibiotics or any probiotic pills or powders in the last month.
- You cannot be allergic to dairy products.
- You must be willing to follow the study plan and give written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special probiotic supplement (ExoBDNF) to see if it can improve memory, thinking, sleep, and mood in healthy adults. You may be able to join if you are generally healthy and not taking probiotics.
This study tests whether a probiotic (a supplement with helpful bacteria) can help slow down memory and thinking problems in people with mild cognitive impairment (MCI). It is for adults aged 60–85 who have noticed their memory getting worse over time but can still handle daily activities.
This study looks at how a probiotic supplement affects the gut and thinking in older adults, including those with mild cognitive impairment or Alzheimer's. It may help explain if improving gut health can support brain health.
This trial tests a new probiotic (Lactococcus lactis CKDB001) to see if it can slow memory loss in people with early Alzheimer's. It’s a 12-week study that requires a positive amyloid PET scan and allows mild to moderate symptoms.
This study tests whether daily probiotics (beneficial bacteria) can help people with mild Alzheimer's disease. It's an early-phase trial to see if probiotics are safe and might improve thinking and memory.
This study tests whether a precision probiotic supplement can help people with mild cognitive impairment (MCI) who also have signs of amyloid buildup in the brain. If you qualify, you would be randomly assigned to take the probiotic or a placebo for a period of time.
Hear when a new Subjective Cognitive Decline (SCD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.